Compositions and methods for the treatment of the metabolically impaired
and for improved compliance
    5.
    发明授权
    Compositions and methods for the treatment of the metabolically impaired and for improved compliance 失效
    用于治疗代谢障碍和改善依从性的组合物和方法

    公开(公告)号:US5521208A

    公开(公告)日:1996-05-28

    申请号:US99304

    申请日:1993-07-29

    申请人: Billie M. York

    发明人: Billie M. York

    IPC分类号: A61K31/415 A61K31/40

    摘要: Disclosed are novel compositions comprising mixtures useful to treat the metabolically impaired and to improve patient compliance. Included are non-racemic mixtures of certain chiral spirofluorenehydantoins. Methods of use to treat glucose toxicity and complications arising from diabetes mellitus are also disclosed.

    摘要翻译: 公开了包含可用于治疗代谢障碍并改善患者依从性的混合物的新型组合物。 包括某些手性螺芴壬内酯的非外消旋混合物。 还公开了用于治疗葡萄糖毒性的方法和由糖尿病引起的并发症。

    B.sub.2 adrenegic agonists and use thereof in the treatment of glaucoma
    6.
    发明授权
    B.sub.2 adrenegic agonists and use thereof in the treatment of glaucoma 失效
    B2 adrengic激动剂及其在治疗青光眼中的用途

    公开(公告)号:US5314916A

    公开(公告)日:1994-05-24

    申请号:US49462

    申请日:1993-04-19

    摘要: Compounds having beta-2 adrenergic agonist activity and the use of these compounds in controlling intraocular pressure are disclosed. The compounds are believed to be useful in controlling intraocular pressure by increasing the outflow of aqueous humor. The compounds are considered to be less likely to cause cardiovascular side effects and various other side effects associated with stimulation of beta-1 receptors, relative to epinephrine.

    摘要翻译: 公开了具有β-2肾上腺素能激动剂活性的化合物和这些化合物在控制眼压中的用途。 据信这些化合物可用于通过增加房水的流出来控制眼内压。 认为这些化合物相对于肾上腺素不太可能引起与β-1受体的刺激相关的心血管副作用和各种其它副作用。

    Treatment of diabetic complications with certain
spiro-imidazolidine-diones
    10.
    发明授权
    Treatment of diabetic complications with certain spiro-imidazolidine-diones 失效
    用某些螺 - 咪唑烷 - 二恶英治疗糖尿病并发症

    公开(公告)号:US4540700A

    公开(公告)日:1985-09-10

    申请号:US577692

    申请日:1984-02-07

    CPC分类号: C07D235/02 Y10S514/866

    摘要: Inhibition of aldose reductase activity with tetracyclic spiro-hydantoins, new tetracyclic spirohydantoin derivatives useful in the treatment of complications arising from diabetes mellitus, and a process for preparing spiro-imidazolidine-diones by reacting a mono- or di-fluorofluorene with an excess of oxygen and a tetralkyl- or arylalkyl-trialkyl-ammonium hydroxide are disclosed.

    摘要翻译: 使用四环螺乙内酯抑制醛糖还原酶活性,可用于治疗糖尿病并发症的新型四环螺乙内酰脲衍生物,以及通过使单 - 或二 - 氟芴与过量的氧反应来制备螺 - 咪唑烷 - 二氢睾酮的方法 和四烷基 - 或芳基烷基 - 三烷基 - 氢氧化铵。